LOWELL ROBERTSON: Open Payments
NPI 1164070314 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 12 payments from 5 companies in 2025. Trend: 2023 $532 · 2024 $746 · 2025 $632
Food & beverage: $512Education: $119
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $383 |
| Janssen Pharmaceuticals, Inc | 2 | $162 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Alkermes, Inc. | 1 | $17 |
Products named: INVEGA SUSTENNA, UZEDY, AUSTEDO XR, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, ABILIFY MAINTENA.
Industry payments across OK — which companies pay providers there.
